Prevention of Oral Mucositis in Head and Neck Cancer. (OMHNC-1)
Oral Mucositis
About this trial
This is an interventional treatment trial for Oral Mucositis
Eligibility Criteria
Inclusion Criteria: Patients with diagnosis of the following HNC: oral cavity, pharynx, unknown primary, salivary glands, undergoing local radiotherapy for curative purpose Patients with diagnosis of HNC: oral cavity, pharynx, unknown primary, salivary glands, undergoing local radiotherapy as an adjuvant to surgical resection Patients able self-apply the product. Exclusion Criteria: Patients with documented contraindication to any of the components of "Gel X" (there included eccipients): water, saccharin sodium, PVP, Taurine, Zinc Gluconate, PEG-40, Hydrogenated castor oil, Pullulan, Flavors Patients with any neurological and psychiatric condition having an influence on the ability to self-apply the treatment Patients participating to other clinical studies
Sites / Locations
- Catholic University of the Sacred HearthRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Test
Control
The investigational product be administered for 63 days. Patient will use a spray based on zinc gluconate (three times a day)
The investigational product be administered for 63 days. Patient will use a solution based on sodium chloride and bicarbonate (5 times a day)